Seroepidemiology of hepatitisC in cases with history of intravenous drug use in Isfahan province, Iran
Abstract number: P1138
Ataei B., Adibi P., Yaran M., Kassaian N., Nokhodian Z., Meshkati M., Fadaei Nobari R.
Objectives: Hepatitis C virus (HCV) which is prevalent among estimated 3% of the world population continues to be a major disease burden on the world.
Several studies have documented that injecting drug use is a primary mode of transmission for HCV. But, there is limited information of HCV detection among intravenous drug users (IVDU) in Iran and in Isfahan there is not any documentation about it. Hence, the present study was conducted to understand the status of HCV infection among IVDUs in Isfahan province, Iran.
Methods: In a cross sectional study, during November 2008-March 2009, the cases with history of intravenous drug using in Isfahan, Iran from drug treatment centers, prisons and community, came into study. HCV-Ab was tested by ELISA, Diapro kit (Italy) and confirmed by RIBA test.
Results: There were 3284 cases (3251 male and 33 women): 1006 in prisons, 531 in drop in centers (DIC) and 1747 in community. The totally prevalence of HCV was 38% which was 40% in prisons, 47% in DICs and 34% from community announcement.
Conclusion: It is important that high prevalence of HCV infection be taken into consideration. Comprehensive harm reduction programs and routine testing are needed for IVDUs in Iran in order to best control further transmission of this infection.
|Session name:||Abstracts 20th European Congress of Clinical Microbiology and Infectious Diseases|
|Location:||Vienna, Austria, 10 - 13 April 2010|
|Back to top|